Diagnostic performance of circulating microRNAs for the early diagnosis of different types of acute cerebrovascular disease
Open Access
- 5 October 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0359648
Abstract
Early differentiation of acute cerebrovascular conditions is important for timely clinical management, while blood-based markers that could complement established diagnostic approaches remain under investigation. This exploratory case-control study evaluated the circulating expression and diagnostic performance of seven candidate microRNAs (miRNAs) in acute ischemic stroke (AIS), hemorrhagic stroke (HS), and transient ischemic attack (TIA) during the first 12 h after symptom onset. The study included 200 participants: 50 patients with AIS, 50 with HS, 50 with TIA, and 50 controls. Plasma was collected from the clinical groups at 3–4.5 h and 12 h after symptom onset and from controls at a single time point. Expression levels of let-7e-5p, miR-21-5p, miR-107, miR-125b-5p, miR-130a-3p, miR-143-3p, and miR-222-3p were measured using real-time quantitative polymerase chain reaction (RT-qPCR). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis and binary logistic regression. let-7e-5p showed the most consistent expression pattern, with lower levels in AIS, HS, and TIA than in controls at both sampling time points. miR-107 was lower in AIS and HS than in controls at both time points, whereas miR-125b-5p showed a predominantly AIS-related pattern. Among comparisons with controls, let-7e-5p yielded the highest individual area under the ROC curve (AUC), reaching 0.867 for AIS at 12 h, whereas miR-222-3p yielded the highest individual AUC for AIS versus HS (0.833 at 12 h). Multi-miRNA models did not significantly improve discrimination over the best-performing individual markers. In the complete-case subset, adding let-7e-5p to a model comprising routinely available clinical variables was associated with a higher AUC for AIS versus controls (0.982) than either component alone. Overall, the observed expression and discrimination patterns support further investigation of circulating miRNAs as complementary markers in acute cerebrovascular disease. Prospective evaluation in larger, independent cohorts, including patients with stroke-mimicking conditions, is needed to determine their diagnostic performance and incremental value in real-world clinical settings.Keywords
Funding Information
- Ministry of Higher Education and Scientific Research (AP23490807)
This publication has 38 references indexed in Scilit:
- Early-phase fluid diagnostic biomarkers in acute ischemic stroke: a hybrid umbrella reviewJournal of Neurology, 2026
- The role of microRNAs as super-early biomarkers in acute ischemic stroke: A systematic reviewClinical Neurology and Neurosurgery, 2024
- Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic StrokeJAMA, 2024
- Non-coding RNAs versus protein biomarkers to diagnose and differentiate acute stroke: Systematic review and meta-analysisJournal of Stroke and Cerebrovascular Diseases, 2023
- The expression levels of circulating miR‐140‐3p, miR‐130a‐3p, and miR‐320b as diagnostic biomarkers in acute ischemic strokeThe Kaohsiung Journal of Medical Sciences, 2023
- Dynamic release of neuronal extracellular vesicles containing miR‐21a‐5p is induced by hypoxiaJournal of Extracellular Vesicles, 2023
- MiR-107 Aggravates Oxygen-Glucose Deprivation/Reoxygenation (OGD/R)-Induced Injury Through Inactivating PI3K-AKT Signalling Pathway by Targeting FGF9/FGF12 in PC12 CellsJournal of Stroke and Cerebrovascular Diseases, 2022
- Using Extracellular Circulating microRNAs to Classify the Etiological Subtypes of Ischemic StrokeTranslational Stroke Research, 2018
- Plasma miR-124 Is a Promising Candidate Biomarker for Human Intracerebral Hemorrhage StrokeMolecular Neurobiology, 2017
- Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis via targeting FASLGThrombosis Research, 2016